Webster Bank N. A. Buys 150 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Webster Bank N. A. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 87.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 321 shares of the medical equipment provider’s stock after acquiring an additional 150 shares during the quarter. Webster Bank N. A.’s holdings in Intuitive Surgical were worth $143,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $1,313,238,000. WCM Investment Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $575,536,000. Capital Research Global Investors bought a new stake in Intuitive Surgical in the 1st quarter valued at $374,390,000. Assenagon Asset Management S.A. lifted its position in Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after acquiring an additional 678,375 shares in the last quarter. Finally, Coatue Management LLC boosted its stake in Intuitive Surgical by 65.7% in the 4th quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock worth $439,106,000 after purchasing an additional 516,054 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.0 %

NASDAQ ISRG traded down $0.19 on Friday, hitting $463.43. The company’s stock had a trading volume of 1,022,572 shares, compared to its average volume of 1,568,958. The company’s 50-day moving average is $437.17 and its 200 day moving average is $404.25. The firm has a market cap of $164.38 billion, a PE ratio of 83.65, a PEG ratio of 4.97 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $468.78.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same quarter in the prior year, the firm posted $1.18 earnings per share. The business’s quarterly revenue was up 14.5% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on ISRG shares. Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Evercore ISI decreased their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a report on Friday, July 19th. Robert W. Baird lifted their target price on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Finally, Morgan Stanley raised their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $442.30.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 284 shares of Intuitive Surgical stock in a transaction on Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $110,521.44. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,142,714.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at $343,628.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 284 shares of Intuitive Surgical stock in a transaction on Monday, May 13th. The shares were sold at an average price of $389.16, for a total transaction of $110,521.44. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,142,714.96. The disclosure for this sale can be found here. Insiders have sold a total of 15,766 shares of company stock worth $6,802,276 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.